Rhoen Klinikum AG (LTS:0NQH) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0NQH Rhoen Klinikum AG LTS:0NQH
73 GF Score
Price €14.65
GF Value €13.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Rhoen Klinikum AG Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Rhoen Klinikum AG is: Moderate Risk: Sensitive, better choose undervalued stock.

Rhoen Klinikum AG  (LTS:0NQH) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Rhoen Klinikum AG Risk Assessment Related Terms

LTS:0NQH vs HCA, THC, EHC: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhoen Klinikum AG Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's Risk Assessment falls into.


LTS:0NQH
73GF Score
Rhoen Klinikum AG LTS:0NQH
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rhoen Klinikum AG (LTS:0NQH) Overvalued in 2026?

Based on GuruFocus' analysis, Rhoen Klinikum AG stock appears to be overvalued. The current stock price of €14.65 is trading 8.6% above its estimated GF Value™ of €13.49. GuruFocus considers Rhoen Klinikum AG to be Fairly Valued.

Key valuation signals for LTS:0NQH:

  • Risk Assessment:
  • GF Value™: €13.49 vs. price of €14.65 (8.6% above fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the LTS:0NQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rhoen Klinikum AG Business Description

Other Exchanges RHK:Germany
Address Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616
Rhoen Klinikum AG provides medical care and healthcare services. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on inpatient, semi-inpatient and outpatient healthcare basis. The company generates the entire revenue in Germany, with the Bavaria and Hesse regions contributing the majority proportions of revenue.
73GF Score

Get the complete analysis for LTS:0NQH

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.65
Price
€13.49
GF Value